wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37737468-1CF0E9D9-8C02-406B-9ED2-CC39B614A9BC
Q37737468-1CF0E9D9-8C02-406B-9ED2-CC39B614A9BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737468-1CF0E9D9-8C02-406B-9ED2-CC39B614A9BC
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain
P1476
Q37737468-1CF0E9D9-8C02-406B-9ED2-CC39B614A9BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737468-1CF0E9D9-8C02-406B-9ED2-CC39B614A9BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3cfc0bda08112b3ac02a8cff643af5e8b4b8624d
P1476
Liraglutide Versus Lixisenatid
......
nt of Type 2 Diabetes in Spain
@en